Comparative study on acute management of intracerebral haematoma using local thrombolysis in moyamoya and non-moyamoya patients: a single institution experience

References

• Feigin VL, Krishnamurthi RV, Parmar P, et al. Writing Group; GBD 2013 Stroke Panel Experts Group: update on the global burden of ischemic and hemorrhagic stroke in 1990–2013: the GBD 2013 study. Neuroepidemiology 2013;45:161–76.
   Web of Science ®Google Scholar
• Al-Shahi Salman R, Klijn CJM, Selim M. Minimally invasive surgery plus alteplase for intracerebral haemorrhage. Lancet 2019;393:965–7.
   PubMed Web of Science ®Google Scholar
• Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM. STICH II Investigators: early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet 2013;382:397–408.
   PubMed Web of Science ®Google Scholar
• Hanley DF, Thompson RE, Rosenblum M, et al. MISTIE III investigators: efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet 2019;393:1021–32.
   PubMed Web of Science ®Google Scholar
• Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med 2009;360:1226–37.
   PubMed Web of Science ®Google Scholar
• Kang S, Liu X, Zhang D, et al. Natural course of moyamoya disease in patients with prior hemorrhagic stroke. Stroke 2019;50:1060–6.
   PubMed Web of Science ®Google Scholar
• Mino M, Fujimura M, Endo H, Endo T, Sato K, Tominaga T. Neuro-endoscopic management of hemorrhagic moyamoya disease in the acute stage: single institute experience. Neurol Res 2019;41:1097–103.
   PubMed Web of Science ®Google Scholar
• Xu F, Lian L, Liang Q, et al. Is it dangerous to treat spontaneous intracerebral hemorrhage by minimally invasive surgery plus local thrombolysis in patients with coexisting unruptured intracranial aneurysms? Clin Neurol Neurosurg 2019;180:62–7.
   PubMed Web of Science ®Google Scholar
• Xu F, Lian L, Liang Q, et al. Extensive basal ganglia hematomas treated by local thrombolysis versus conservative management – a comparative retrospective analysis. Br J Neurosurg 2016;30:401–6.
   PubMed Web of Science ®Google Scholar
• Goulay R, Naveau M, Gaberel T, Vivien D, Parcq J. Optimized tPA: a non-neurotoxic fibrinolytic agent for the drainage of intracerebral hemorrhages. J Cereb Blood Flow Metab 2018;38:1180–9.
   PubMed Web of Science ®Google Scholar
• Rohde V, Uzma N, Thiex R, Samadani U. Management of delayed edema formation after fibrinolytic therapy for intracerebral hematomas: preliminary experimental data. Acta Neurochir Suppl 2008;105:101–4.
   PubMedGoogle Scholar
• Malik P, Patel UK, Kaul S, et al. Risk factors and outcomes of intravenous tissue plasminogen activator and endovascular thrombectomy utilization amongst pediatrics acute ischemic stroke. Int J Stroke 2021;16(2):172–183.
   PubMedGoogle Scholar
• Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology: Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015;46:2032–60.
   PubMed Web of Science ®Google Scholar
• Xu F, Lian L, Liang Q, et al. Good functional outcome following bilateral external capsule hemorrhage mimicking bilateral basal ganglia hemorrhage in a coma patient. Br J Neurosurg 2019;29:1–3.
   Google Scholar
• Anderson CS, Heeley E, Huang Y, et al. INTERACT2 investigators: rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013;368:2355–65.
   PubMed Web of Science ®Google Scholar
• Fujimura M, Funaki T, Houkin K, et al. Intrinsic development of choroidal and thalamic collaterals in hemorrhagic-onset moyamoya disease: case-control study of the Japan Adult Moyamoya Trial. J Neurosurg 2018;4:1–7.
   Google Scholar
• Miyamoto S, Yoshimoto T, Hashimoto N, et al. JAM Trial Investigators: Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke 2014;45:1415–21.
   PubMed Web of Science ®Google Scholar
• Iwama T, M orimoto M, Hashim oto N, Goto Y, Todaka T, Sawada M. Mechanism of intracranial rebleeding in moyamoya disease. Clin Neurol Neurosurg 1997;99:S187–S190.
   PubMed Web of Science ®Google Scholar
• Funaki T, Takahashi JC, Houkin K, et al. Effect of choroidal collateral vessels on de novo hemorrhage in moyamoya disease: analysis of nonhemorrhagic hemispheres in the Japan Adult Moyamoya Trial. J Neurosurg 2019;132:408–14.
   PubMed Web of Science ®Google Scholar
• Manning L, Hirakawa Y, Arima H, et al. Anderson CS; INTERACT2 investigators: blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial. Lancet Neurol 2014;13:364–73.
   PubMed Web of Science ®Google Scholar
• Brunner F, Tomandl B, Schröter A, et al. Hemorrhagic complications after systemic thrombolysis in acute stroke patientswith abnormal baseline coagulation. Eur J Neurol 2011;18:1407–11.
   PubMed Web of Science ®Google Scholar
• Kano H, Kondziolka D, Flickinger JC, et al. Aneurysms increase the risk of rebleeding after stereotactic radiosurgery for hemorrhagic arteriovenous malformations. Stroke 2012;43:2586–91.
   PubMed Web of Science ®Google Scholar
• Nishihara T, Nagata K, Tanaka S, et al. Newly developed endoscopic instruments for the removal of intracerebral hematoma. Neurocrit Care 2005;2:67–74.
   PubMed Web of Science ®Google Scholar